The present invention provides safe and effective methods for the treatment of sialorrhea (excessive drooling) by administering an effective amount of N-desethyloxybutynin, or an optical R- or S-isomer thereof. N-desethyloxybutynin is a metabolite of oxybutynin and has higher affinity for receptors present in the parotid glands (the salivary glands in humans) than oxybutynin.
本发明提供了一种安全有效的方法,通过给予足够的N-去乙氧基丁
铵或其光学R-或S-异构体来治疗口涎过多(多流口
水)的症状。N-去乙氧基丁
铵是奥昔布汀(一种抗
胆碱能药物)的代谢物,对于人类腮腺(唾液腺)中存在的受体具有更高的亲和力。